 Kathryn Beauchamp
Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endotamponade | 2 | 2015 | 4 | 1.080 |
Why?
| | Brain Injuries | 8 | 2015 | 484 | 1.020 |
Why?
| | Intracranial Hemorrhages | 2 | 2015 | 77 | 1.020 |
Why?
| | Intraoperative Complications | 2 | 2015 | 131 | 0.970 |
Why?
| | Craniotomy | 2 | 2015 | 69 | 0.960 |
Why?
| | Decompressive Craniectomy | 3 | 2014 | 11 | 0.960 |
Why?
| | Intracranial Hypertension | 3 | 2014 | 41 | 0.910 |
Why?
| | Cranial Fossa, Posterior | 1 | 2015 | 17 | 0.550 |
Why?
| | Craniosynostoses | 1 | 2015 | 28 | 0.530 |
Why?
| | Arnold-Chiari Malformation | 1 | 2015 | 30 | 0.530 |
Why?
| | Neurosurgical Procedures | 1 | 2015 | 164 | 0.490 |
Why?
| | Cerebellum | 1 | 2015 | 203 | 0.470 |
Why?
| | Hypertension, Malignant | 1 | 2013 | 2 | 0.470 |
Why?
| | Brain Damage, Chronic | 1 | 2013 | 24 | 0.460 |
Why?
| | Cerebral Infarction | 1 | 2013 | 45 | 0.450 |
Why?
| | Neurologic Examination | 1 | 2013 | 126 | 0.440 |
Why?
| | Cervical Vertebrae | 2 | 2010 | 115 | 0.420 |
Why?
| | Hospital Mortality | 1 | 2015 | 814 | 0.400 |
Why?
| | Hypothermia, Induced | 1 | 2010 | 68 | 0.350 |
Why?
| | Skull | 1 | 2010 | 127 | 0.350 |
Why?
| | Football | 1 | 2010 | 89 | 0.350 |
Why?
| | Craniocerebral Trauma | 1 | 2010 | 146 | 0.330 |
Why?
| | Spinal Cord Injuries | 2 | 2013 | 184 | 0.330 |
Why?
| | Treatment Outcome | 8 | 2015 | 9341 | 0.250 |
Why?
| | Vertebral Artery | 2 | 2014 | 27 | 0.240 |
Why?
| | Carotid Artery Injuries | 2 | 2014 | 42 | 0.240 |
Why?
| | Glasgow Coma Scale | 3 | 2015 | 150 | 0.240 |
Why?
| | Head Injuries, Penetrating | 2 | 2015 | 8 | 0.230 |
Why?
| | Postoperative Complications | 2 | 2013 | 2235 | 0.220 |
Why?
| | Head Injuries, Closed | 2 | 2015 | 55 | 0.210 |
Why?
| | Complement Membrane Attack Complex | 2 | 2020 | 35 | 0.210 |
Why?
| | Wounds, Nonpenetrating | 2 | 2014 | 285 | 0.190 |
Why?
| | Spinal Fractures | 2 | 2013 | 77 | 0.170 |
Why?
| | Survival Rate | 2 | 2015 | 1720 | 0.170 |
Why?
| | Frontal Bone | 1 | 2017 | 13 | 0.150 |
Why?
| | Facial Injuries | 1 | 2017 | 19 | 0.150 |
Why?
| | Sampling Studies | 1 | 2015 | 92 | 0.140 |
Why?
| | Brain Injuries, Traumatic | 1 | 2020 | 318 | 0.130 |
Why?
| | Injury Severity Score | 3 | 2014 | 528 | 0.130 |
Why?
| | Infant | 4 | 2015 | 8293 | 0.130 |
Why?
| | Carotid Artery, Internal | 1 | 2014 | 34 | 0.120 |
Why?
| | Risk Assessment | 2 | 2015 | 3055 | 0.120 |
Why?
| | Intracranial Pressure | 1 | 2014 | 53 | 0.120 |
Why?
| | Humans | 18 | 2020 | 118931 | 0.120 |
Why?
| | Fracture Fixation | 2 | 2013 | 81 | 0.110 |
Why?
| | Thoracic Vertebrae | 1 | 2013 | 72 | 0.110 |
Why?
| | Biomechanical Phenomena | 1 | 2015 | 683 | 0.110 |
Why?
| | Phenytoin | 1 | 2012 | 14 | 0.110 |
Why?
| | Piracetam | 1 | 2012 | 15 | 0.110 |
Why?
| | Male | 10 | 2015 | 57784 | 0.100 |
Why?
| | Fractures, Bone | 1 | 2017 | 380 | 0.100 |
Why?
| | Adult | 10 | 2017 | 31508 | 0.100 |
Why?
| | Young Adult | 4 | 2015 | 10793 | 0.100 |
Why?
| | Lumbar Vertebrae | 1 | 2013 | 215 | 0.100 |
Why?
| | Tomography, X-Ray Computed | 3 | 2014 | 2436 | 0.090 |
Why?
| | Stents | 1 | 2014 | 457 | 0.090 |
Why?
| | Anticonvulsants | 1 | 2012 | 184 | 0.090 |
Why?
| | Endovascular Procedures | 1 | 2014 | 276 | 0.090 |
Why?
| | Femoral Fractures | 1 | 2010 | 67 | 0.090 |
Why?
| | CD59 Antigens | 1 | 2009 | 21 | 0.090 |
Why?
| | Brain Edema | 1 | 2009 | 61 | 0.090 |
Why?
| | Seizures | 1 | 2012 | 345 | 0.080 |
Why?
| | Pipecolic Acids | 1 | 2008 | 22 | 0.080 |
Why?
| | Blood-Brain Barrier | 1 | 2009 | 108 | 0.080 |
Why?
| | Middle Aged | 6 | 2015 | 27607 | 0.080 |
Why?
| | Female | 9 | 2017 | 61547 | 0.080 |
Why?
| | Cyclosporine | 1 | 2008 | 173 | 0.080 |
Why?
| | Wounds, Gunshot | 1 | 2010 | 176 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2015 | 2673 | 0.080 |
Why?
| | Acute Disease | 1 | 2010 | 940 | 0.080 |
Why?
| | Laminectomy | 1 | 2007 | 26 | 0.080 |
Why?
| | Encephalitis | 1 | 2009 | 129 | 0.080 |
Why?
| | Tissue and Organ Procurement | 1 | 2010 | 248 | 0.080 |
Why?
| | Progesterone | 1 | 2008 | 242 | 0.070 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2008 | 191 | 0.070 |
Why?
| | Brain Neoplasms | 1 | 2015 | 1022 | 0.070 |
Why?
| | Child, Preschool | 3 | 2015 | 9491 | 0.070 |
Why?
| | Recovery of Function | 1 | 2010 | 603 | 0.070 |
Why?
| | Burns | 1 | 2009 | 247 | 0.070 |
Why?
| | Databases, Factual | 1 | 2010 | 1231 | 0.070 |
Why?
| | Joint Instability | 1 | 2007 | 172 | 0.060 |
Why?
| | Adrenal Cortex Hormones | 1 | 2008 | 521 | 0.060 |
Why?
| | Spinal Fusion | 1 | 2007 | 225 | 0.060 |
Why?
| | Infant, Newborn | 1 | 2015 | 5255 | 0.060 |
Why?
| | Adolescent | 4 | 2015 | 18480 | 0.060 |
Why?
| | Clinical Trials as Topic | 1 | 2008 | 969 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2009 | 3730 | 0.060 |
Why?
| | Retrospective Studies | 4 | 2014 | 12972 | 0.050 |
Why?
| | Child | 3 | 2015 | 19128 | 0.050 |
Why?
| | Models, Biological | 1 | 2008 | 1715 | 0.050 |
Why?
| | Quality of Life | 1 | 2010 | 2363 | 0.040 |
Why?
| | Complement Activation | 1 | 2020 | 350 | 0.040 |
Why?
| | Complement System Proteins | 1 | 2020 | 294 | 0.040 |
Why?
| | Length of Stay | 2 | 2013 | 1032 | 0.040 |
Why?
| | Brain | 1 | 2009 | 2489 | 0.040 |
Why?
| | Prospective Studies | 2 | 2020 | 6471 | 0.030 |
Why?
| | Biomarkers | 2 | 2020 | 3588 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2014 | 4596 | 0.030 |
Why?
| | Intracranial Thrombosis | 1 | 2014 | 17 | 0.030 |
Why?
| | Cerebral Angiography | 1 | 2014 | 116 | 0.030 |
Why?
| | Accidents, Traffic | 1 | 2014 | 178 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2014 | 6555 | 0.030 |
Why?
| | Propensity Score | 1 | 2014 | 242 | 0.030 |
Why?
| | Animals | 3 | 2009 | 33381 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 2014 | 238 | 0.030 |
Why?
| | Cost Control | 1 | 2012 | 44 | 0.030 |
Why?
| | Decision Trees | 1 | 2012 | 83 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2013 | 238 | 0.030 |
Why?
| | Monte Carlo Method | 1 | 2012 | 146 | 0.030 |
Why?
| | Third-Party Consent | 1 | 2010 | 8 | 0.020 |
Why?
| | Drug Costs | 1 | 2012 | 94 | 0.020 |
Why?
| | Brain Death | 1 | 2010 | 29 | 0.020 |
Why?
| | Time Factors | 2 | 2013 | 6409 | 0.020 |
Why?
| | Mice, Inbred C57BL | 2 | 2009 | 4908 | 0.020 |
Why?
| | Critical Pathways | 1 | 2010 | 78 | 0.020 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2009 | 34 | 0.020 |
Why?
| | Fas Ligand Protein | 1 | 2009 | 60 | 0.020 |
Why?
| | bcl-2-Associated X Protein | 1 | 2009 | 46 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 554 | 0.020 |
Why?
| | fas Receptor | 1 | 2009 | 98 | 0.020 |
Why?
| | Demyelinating Diseases | 1 | 2009 | 79 | 0.020 |
Why?
| | Trauma Centers | 1 | 2010 | 388 | 0.020 |
Why?
| | Zygapophyseal Joint | 1 | 2007 | 8 | 0.020 |
Why?
| | Arthrography | 1 | 2007 | 22 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 226 | 0.020 |
Why?
| | Behavior, Animal | 1 | 2009 | 486 | 0.020 |
Why?
| | Aged | 2 | 2014 | 19644 | 0.020 |
Why?
| | Mice | 2 | 2009 | 15520 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2009 | 2680 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2009 | 2656 | 0.010 |
Why?
| | Neurons | 1 | 2009 | 1345 | 0.010 |
Why?
| | Apoptosis | 1 | 2009 | 2484 | 0.010 |
Why?
|
|
Beauchamp's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|